Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) para Autoimmune Conditions

B

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dautoimmune\u002Dconditions'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusão

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

Key Study Findings

Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None vs: None Outcome: rheumatoid arthritis disease activity modulation through diet Efeito: None None

População: patients with rheumatoid arthritis

Case Reports n=1
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus.
Dose: None vs: None Outcome: GPIHBP1 autoantibody and LPL mass normalization Efeito: None None

População: 12-year-old girl with SLE and severe hypertriglyceridemia

Review
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and …
Dose: None vs: None Outcome: Epigenetic and mitochondrial modulation in MS Efeito: None None

População: Multiple sclerosis patients (review)

Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None vs: None Outcome: RA risk and disease activity Efeito: None None

População: Patients with rheumatoid arthritis

Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None vs: None Outcome: None Efeito: None None

População: None

Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None vs: None Outcome: None Efeito: None None

População: Systematic review of nutraceuticals in rheumatoid arthritis

Key Statistics

10

Estudos

25000

Participantes

Positive

B

Nota

Referenced Papers

BMJ (Clinical research … 2022 9 citações
Nederlands tijdschrift voor … 2022 1 citações
Current atherosclerosis reports 2004 464 citações
Journal of the … 2002 2016 citações
Biochemical Society transactions 1995 15 citações
World review of … 1994 8 citações
The American journal … 1991 2278 citações
Rheumatic diseases clinics … 1991 19 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

Limite superior: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None -- Positive --
None -- Positive 1
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Neutral --

Melhor horário: With meals

Safety & Side Effects

Efeitos Colaterais Relatados

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

Interações Conhecidas

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

Ingestão máxima tolerável: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Autoimmune Conditions?
Based on 10 studies with 25,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (EPA/DHA) may support Autoimmune Conditions management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Autoimmune Conditions?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Autoimmune Conditions?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 25,000 total participants. The overall direction of effect is positive.

Related Evidence

Outros ingredientes para Autoimmune Conditions

Omega-3 Fatty Acids (EPA/DHA) para outras condições

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.